<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">JBM</journal-id><journal-title-group><journal-title>Journal of Biosciences and Medicines</journal-title></journal-title-group><issn pub-type="epub">2327-5081</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/jbm.2023.1111004</article-id><article-id pub-id-type="publisher-id">JBM-128885</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biomedical&amp;Life Sciences</subject></subj-group></article-categories><title-group><article-title>
 
 
  Prevalence and Associated Factors of Viral Hepatitis C among Burundian Population during a Screening Campaign: A Cross-Sectional Study Carried out in Burundi
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Nahimana</surname><given-names>Tharcisse</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ndihokubwayo</surname><given-names>Armstrong</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Hakizimana</surname><given-names>Emmanuel</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ihorimbere</surname><given-names>Theogene</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Niyonizeye</surname><given-names>Emile</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Butoyi</surname><given-names>Pascal</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Harimenshi</surname><given-names>Deo</given-names></name><xref ref-type="aff" rid="aff6"><sup>6</sup></xref></contrib></contrib-group><aff id="aff2"><addr-line>National Reference Laboratory, National Institute of Public Health, Bujumbura, Burundi</addr-line></aff><aff id="aff1"><addr-line>Faculty of Medicine and Health Sciences, University of Ngozi, Ngozi, Burundi</addr-line></aff><aff id="aff5"><addr-line>Consultant UNDP, Bujumbura, Burundi</addr-line></aff><aff id="aff4"><addr-line>Department of Clinical Hematology, Zhengzhou University, Zhengzhou, China</addr-line></aff><aff id="aff3"><addr-line>Van Norman Clinic &amp;amp; Hope Africa University Hospital, Hope Africa University, Bujumbura, Burundi</addr-line></aff><aff id="aff6"><addr-line>National Institute of Public Health, Bujumbura, Burundi</addr-line></aff><pub-date pub-type="epub"><day>01</day><month>11</month><year>2023</year></pub-date><volume>11</volume><issue>11</issue><fpage>33</fpage><lpage>44</lpage><history><date date-type="received"><day>28,</day>	<month>September</month>	<year>2023</year></date><date date-type="rev-recd"><day>4,</day>	<month>November</month>	<year>2023</year>	</date><date date-type="accepted"><day>7,</day>	<month>November</month>	<year>2023</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Approximately 180 million people worldwide are affected by Viral hepatitis C, with 350,000 to 500,000 deaths yearly. The present study sought to investigate the prevalence and associated factors of viral hepatitis C (VHC) among the Burundian population during a screening campaign. A total of 629 participants took part in the study, and the prevalence of viral hepatitis C was (8.11%). The associated factors identified as statistically associated were medical and surgical history (P = 0.02) and ear and nose piercing (P = 0.01). 51% of the infected persons were females. The mean age for viral hepatitis C carriage was 46.13 &#177; 14.3 years and 10.40% of viral hepatitis C carriers were over 50 years old. We found a high viral hepatitis C prevalence in married (9.55%) and divorced (9.38%) participants. The majority of our participants were farmers (60.25%) with a prevalence of viral hepatitis C (7.92%) while 11.54% of the infected participants were not educated. In conclusion, the current study shows a high prevalence of Viral Hepatitis C infection in Burundi. Infection was more likely to occur in older, married, farmer, and illiterates. Unsafe medical and surgical interventions with traditional practitioners were significant risk factors for contracting VHC infection.
 
</p></abstract><kwd-group><kwd>Prevalence</kwd><kwd> VHC</kwd><kwd> Associated Factors</kwd><kwd> Burundi</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="scirp.128885-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">World Health Organization (2016) Global Health Sector Strategy on Viral Hepatitis 2016-2021 towards Ending Viral Hepatitis. WHO, Geneva.</mixed-citation></ref><ref id="scirp.128885-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Lavanchy, D. (2011) Evolving Epidemiology of Hepatitis C Virus. Clinical Microbiology and Infection, 17, 107-115. https://doi.org/10.1111/j.1469-0691.2010.03432.x</mixed-citation></ref><ref id="scirp.128885-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">World Health Organization (2016) Monitoring and Evaluation for Viral Hepatitis B and C: Recommended Indicators and Framework. World Health Organization, Geneva. https://iris.who.int/handle/10665/204790</mixed-citation></ref><ref id="scirp.128885-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Makuza, J.D., et al. (2019) Risk Factors for Viral Hepatitis C Infection in Rwanda: Results from a Nationwide Screening Program. BMC Infectious Diseases, 19, Article No. 688. https://doi.org/10.1186/s12879-019-4322-7</mixed-citation></ref><ref id="scirp.128885-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Bartenschlager, R., et al. (2018) Critical Challenges and Emerging Opportunities in Hepatitis C Virus Research in an Era of Potent Antiviral Therapy: Considerations for Scientists and Funding Agencies. Virus Research, 248, 53-62. https://doi.org/10.1016/j.virusres.2018.02.016</mixed-citation></ref><ref id="scirp.128885-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Hermine, O., et al. (2002) Regression of Splenic Lymphoma with Villous Lymphocytes after Treatment of Hepatitis C Virus Infection. The New England Journal of Medicine, 347, 89-94. https://doi.org/10.1056/NEJMoa013376</mixed-citation></ref><ref id="scirp.128885-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Eichhorst, B., et al. (2021) Chronic Lymphocytic Leukaemia: ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-Up. Annals of Oncology, 32, 23-33. https://doi.org/10.1016/j.annonc.2020.09.019</mixed-citation></ref><ref id="scirp.128885-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Richard, N. and Arnaud, F. (2016) Epidémiologie des hépatites virales B, C, et delta au Cameroun: Analyse des échantillons de l’enquête Démographique de Santé 2011. Projet ANRS, 12289.</mixed-citation></ref><ref id="scirp.128885-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Shepard, C.W., Finelli, L. and Alter, M.J. (2005) Global Epidemiology of Hepatitis C Virus Infection. The Lancet Infectious Diseases, 5, 558-567. https://doi.org/10.1016/S1473-3099(05)70216-4</mixed-citation></ref><ref id="scirp.128885-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">World Health Organization (WHO) (2016) Global Health Estimates 2015: Deaths by Cause, Age, Sex, by Country and by Region, 2000-2015. Geneva.</mixed-citation></ref><ref id="scirp.128885-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Zeba, T.A.M. (2012) Co-infection des virus des hépatites B et C au Burkina Faso: Prévalence, marqueurs viraux et caractérisation moléculaire.</mixed-citation></ref><ref id="scirp.128885-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Hahné, S.J., Veldhuijzen, I.K., Wiessing, L., Lim, T.A., Salminen, M. and van de Laar, M. (2013) Infection with Hepatitis B and C Virus in Europe: A Systematic Review of Prevalence and Cost-Effectiveness of Screening. BMC Infectious Diseases, 13, Article No. 181. https://doi.org/10.1186/1471-2334-13-181</mixed-citation></ref><ref id="scirp.128885-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Gower, E., Estes, C., Blach, S., Razavi-Shearer, K. and Razavi, H. (2014) Global Epidemiology and Genotype Distribution of the Hepatitis C Virus Infection. Journal of Hepatology, 61, S45-S57. https://doi.org/10.1016/j.jhep.2014.07.027</mixed-citation></ref><ref id="scirp.128885-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Kilonzo, S.B., et al. (2021) Seroprevalence of Hepatitis B Virus Infection, Anti-HCV Anti-bodies and HIV and Knowledge among People Who Use Drugs Attending Methadone Therapy Clinic in Tanzania; A Cross-Sectional Study. BMC Infectious Diseases, 21, Article No. 699. https://doi.org/10.1186/s12879-021-06393-0</mixed-citation></ref><ref id="scirp.128885-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Lingala, S. and Ghany, M.G. (2015) Natural History of Hepatitis C. Gastroenterology Clinics, 44, 717-734. https://doi.org/10.1016/j.gtc.2015.07.003</mixed-citation></ref><ref id="scirp.128885-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Padovese, V., et al. (2014) Prevalence of Latent Tuberculosis, Syphilis, Hepatitis B and C among Asylum Seekers in Malta. Journal of Public Health, 36, 22-27. https://doi.org/10.1093/pubmed/fdt036</mixed-citation></ref><ref id="scirp.128885-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Umutesi, J., et al. (2017) Prevalence of Hepatitis B and C Infection in Persons Living with HIV Enrolled in Care in Rwanda. BMC Infectious Diseases, 17, Article No. 315. https://doi.org/10.1186/s12879-017-2422-9</mixed-citation></ref><ref id="scirp.128885-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Burundi PLAN STRATEGIE HEPATITES VIRALES (French). https://www.globalhep.org/sites/default/files/content/action_plan_article/files/2020-04/Burundi%20PLAN%20STRATEGIE%20HEPATITES%20VIRALES%20%28French%29.pdf</mixed-citation></ref><ref id="scirp.128885-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Nahimana, T. (2019) Contribution to the Study of the Prevalence of Viral Hepatitis B and C in Burundi: Case of the Regional Center for Blood Transfusion of Ngozi. Ph.D. Thesis, Universite de la Renaissance d’Haiti, Portau-Prince.</mixed-citation></ref><ref id="scirp.128885-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Saaed, F.M.A. and Ongerth, J.E. (2023) Prevalence of Hepatitis B and Hepatitis C in Migrants from Sub-Saharan Africa before Onward Dispersal toward Europe. Journal of Immigrant and Minority Health, 25, 882-888. https://doi.org/10.1007/s10903-022-01448-z</mixed-citation></ref><ref id="scirp.128885-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Sonderup, M.W., et al. (2017) Hepatitis C in Sub-Saharan Africa: The Current Status and Recommendations for Achieving Elimination by 2030. The Lancet Gastroenterology &amp; Hepatology, 2, 910-919. https://doi.org/10.1016/S2468-1253(17)30249-2</mixed-citation></ref><ref id="scirp.128885-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">(2022) Estimations de l’hépatite C au Canada, 2019. RMTC 48 (11/12). https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2022-48/numero-11-12-novembre-decembre-2022/estimations-nationales-hepatite-c-canada-2019.html</mixed-citation></ref><ref id="scirp.128885-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Mapoure, N.Y., et al. (2018) Neurological Manifestations in Chronic Hepatitis C Patients Receiving Care in a Reference Hospital in Sub-Saharan Africa: A Cross-Sectional Study. PLOS ONE, 13, e0192406. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0192406</mixed-citation></ref><ref id="scirp.128885-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Tazinkeng, N.N., et al. (2022) Factors Associated with Hepatitis B and C among Adults in Buea, Cameroon: A Community-Based Cross-Sectional Study. Liver International, 42, 2396-2402. https://doi.org/10.1111/liv.15390</mixed-citation></ref><ref id="scirp.128885-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Ameha, Z., Tadesse, S., Assefa, A. and Tessema, B. (2019) Prevalence and Associated Factors of Hepatitis C Virus and Human Immunodeficiency Virus Infections among Voluntary Counseling and Testing Clients Attending Private Health Facilities in Bahir Dar City, North West Ethiopia 2014. BMC Research Notes, 12, Article No. 693. https://doi.org/10.1186/s13104-019-4727-9</mixed-citation></ref><ref id="scirp.128885-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Davarpanah, M.A., Khademolhosseini, F., Rajaeefard, A., Tavassoli, A., Yazdanfar, S.K. and Rezaianzadeh, A. (2013) Hepatitis C Virus Infection in HIV Positive Attendees of Shiraz Behavioral Diseases Consultation Center in Southern Iran. Indian Journal of Community Medicine, 38, 86-91. https://doi.org/10.4103/0970-0218.112437</mixed-citation></ref><ref id="scirp.128885-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Umumararungu, E., Ntaganda, F., Kagira, J. and Maina, N. (2017) Prevalence of Hepatitis C Virus Infection and Its Risk Factors among Patients Attending Rwanda Military Hospital, Rwanda. BioMed Research International, 2017, Article ID: 5841272. https://doi.org/10.1155/2017/5841272</mixed-citation></ref><ref id="scirp.128885-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">Zacks, S., et al. (2006) Social Stigmatization and Hepatitis C Virus Infection. Journal of Clinical Gastro-enterology, 40, 220-224. https://doi.org/10.1097/00004836-200603000-00009</mixed-citation></ref><ref id="scirp.128885-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">Eze, J.C., Ibeziako, N.S., Ikefuna, A.N., Nwokoye, I.C., Uleanya, N.D. and Ilechukwu, G.C. (2014) Prevalence and Risk Factors for Hepatitis C and Human Immunodeficiency Virus Coinfection among Children in Enugu, Nigeria. African Journal of Infectious Diseases, 8, 5-8. https://doi.org/10.4314/ajid.v8i1.2</mixed-citation></ref></ref-list></back></article>